509 S Exeter Street #202,
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.
CEO: Jeffrey B. Kindler
Chief Veterinary Officer: Peter Hanson, DVM, Ph.D.
Chief Business Officer: Kerrie Brady, BPharm, MS, MBA
CFO: Gregg Beloff, J.D., MBA
Please click here for clinical trial information.